小指标大风险！华润双鹤利民药业、辰欣药业双双被罚

Group 1 - China Resources Double Crane and Limin Pharmaceutical were fined 1 million and 3 million yuan respectively for producing sodium bicarbonate injection that failed to meet key quality indicators, specifically "visible foreign matter" and "pH value" [1][5] - The penalties were based on violations of Article 98 of the Drug Administration Law, which outlines strict regulations for drug production [1] - The specific batches involved were identified as 24120602 for China Resources Double Crane and K24110334 for Limin Pharmaceutical, with a total of 23,000 and 30,464 units respectively being deemed non-compliant [3][5] Group 2 - The fines imposed on Limin Pharmaceutical included the confiscation of all non-compliant products and a recovery of illegal gains amounting to 197.5 yuan [3] - For China Resources Double Crane, the total penalty reached 3.0317 million yuan, including the confiscation of illegal gains of 93,300 yuan, bringing the total to 3.125 million yuan [6] - Both companies were penalized following a notice from the National Medical Products Administration regarding 28 batches of non-compliant drugs, highlighting the regulatory scrutiny in the pharmaceutical industry [6]